Safety Study of the Rapid System for Acute Ischemic Stroke
NCT01404403 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2013-11-05
Summary
This is a safety study of the Rapid System for acute ischemic stroke.
Conditions
- Acute Ischemic Stroke
Interventions
- DEVICE
-
Rapid System
Sponsors & Collaborators
-
Rapid Medical
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- Sweden
Study Locations
More Related Trials
-
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
NCT04129125 ·Status: COMPLETED ·Phase: NA
-
Mild and Rapidly Improving Stroke Study
NCT02072681 ·Status: COMPLETED
-
Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke
NCT05342038 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
Argatroban Plus R-tPA for Acute Ischemic Stroke
NCT03740958 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke
NCT07113184 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke
NCT03192332 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
NCT03346538 ·Status: TERMINATED ·Phase: PHASE2
-
Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy
NCT03198715 ·Status: COMPLETED ·Phase: NA
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
NCT02907736 ·Status: WITHDRAWN
-
Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-Tissue Plasminogen Activator (IV-tPA)
NCT01331200 ·Status: COMPLETED
-
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
NCT01955707 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
NCT05198323 ·Status: RECRUITING ·Phase: PHASE2
-
RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction
NCT07203521 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
NCT06241677 ·Status: RECRUITING ·Phase: NA
-
N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE
NCT04920448 ·Status: TERMINATED ·Phase: PHASE2
-
SITS-IVT in Patients >80 Years Study
NCT04260347 ·Status: COMPLETED
-
Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
NCT02730455 ·Status: COMPLETED ·Phase: PHASE2
-
Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS)
NCT00540527 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2